Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals
4484 Congresses
10100+ Unique Records

Drugs - Real World Outcomes


Title Abbreviation
Drugs Real World Outcomes
Electronic ISSN
2198-9788
Readership
Academics, Advanced Practice Nurses, Advanced Practice Trauma Nurses, Allergists, Allied Health Professionals, Andrologists, Anesthesiologists, Cardiologists, Caregivers, Clinical Pharmacologists, Clinicians, Critical Care Nurses, Critical Care Physicians, Dermatologists, Electrophysiologists, Emergency Nurses, Emergency Physicians, Endocrinologists, Family Practice Physicians, Gastroenterologists, General Practitioners, Gynecologists, Health Service Researchers, Healthcare Executives, Hematologists, Hepatologists, Hospice Nurses, Infectious Disease Specialists, Neonatologists, Nephrologists, Neurologists, Nurse Practitioners, Obstetricians, Oncologists, Ophthalmologists, Outcomes Manager, Pain Specialists, Patients, Pediatricians, Perinatologists, Pharmacologists, Physiatrists, Primary Care Physicians, Pulmonologists, Researchers, Rheumatologists, Urologists
Scope
Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: - Using registries/databases/health records and other non-selected observational datasets to investigate: - drug use and treatment outcomes prescription patterns - drug safety signals - adherence to treatment guidelines - benefit : risk profiles - comparative effectiveness - economic analyses including cost-of-illness - Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’ - Techniques and approaches to optimise real-world modelling. Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Adis, part of Springer Nature
To see more details about Drugs - Real World Outcomes, Subscribe Now!
Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library